<DOC>
	<DOCNO>NCT02785523</DOCNO>
	<brief_summary>A phase III double-blind randomize clinical trial effect ganoderma spore lipids immunological response patient G.I . Cancers . The trial randomize , double-blind . Cancer patient diagnose base pathology cell biology . Patients randomize 2 group : group receive chemotherapy . Either group receive ganoderma spore lipid placebo capsule 600mg three time day ( TID ) addition chemotherapy . Clinical evaluation include chemotherapy drug toxicity , life quality improvement . Blood biochemistry test mainly include malondialdehyde ( MDA ) , superoxide dismutase ( SOD ) , glutathione peroxidase ( GSH-Px ) , adrenaline , nor-adrenaline , tumor necrosis factor ( TNF ) -Î± , interleukin ( IL ) -1b , interleukin ( IL ) -6 , cell flow cytometry Th1 , Th2 , Th17 , Treg cytokine , well serum cortisol , estradiol ( female ) , progesterone ( female ) , testosterone ( male ) , etc .</brief_summary>
	<brief_title>Clinical Trial Ganoderma Spore Lipids Combined With Chemo Patients With G.I . Cancers</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<criteria>Age : 1880 , male female . Diagnosis : imaging , cell pathology report . Eastern Cooperative Oncology Group ( ECOG ) O2 , life expectancy 3 month . Chemotherapy contraindicate . No apparent surgical trauma previous 2 week . Past treatment : Biological treatment : least 4 week previous treatment immunotherapy biological ; chemotherapy , least 6 month last treatment chemotherapy target therapy . Surgery : receive transplantation surgery , least 2 week last major surgery . A purulent chronic infection wound heal delay . Diseases blood system . Abnormal blood coagulation function . Severe brain disease primary brain tumor without control , mentally ill person . Patients brain metastasis . Pregnant lactating woman . Patients ( male/female ) fertility , But patient spouse take effective contraception . Allergic constitution . In addition , patient take part clinical trial , treat biotherapy immunotherapy researcher consider suitable clinical subject reason exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>